| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |